Recent Posts

Standard 3 Column

DF/Net Research Expands Global Footprint into South Africa, forming DF/Net Research Mzansi

JOHANNESBURG, South Africa and SEATTLE, November 2, 2020 -- DF/Net Research, Inc. (DF/Net), an experienced healthcare technology company providing eClinical solutions and data…

Partner News: Syntrix Pharmaceuticals

Syntrix Completes Initial SX-682 Dosing in Broad Phase 1/2 Cancer Trial Campaign Now Encompassing 5 Solid Cancer Types Plus Myelodysplastic Syndromes AUBURN,…

SCDM 2020 Virtual Conference

  We look forward to exhibiting at the SCDM 2020 Virtual Conference on September 13 - 15. We hope you can visit…

Carousel 3 Column

Standard Row

Standard Vertical

DF/Net Research Expands Global Footprint into South Africa, forming DF/Net Research Mzansi
News
DF/Net Research Expands Global Footprint into South Africa, forming DF/Net Research Mzansi

JOHANNESBURG, South Africa and SEATTLE, November 2, 2020 -- DF/Net Research, Inc. (DF/Net), an experienced…

Partner News: Syntrix Pharmaceuticals
News
Partner News: Syntrix Pharmaceuticals

Syntrix Completes Initial SX-682 Dosing in Broad Phase 1/2 Cancer Trial Campaign Now Encompassing…

Post List

DF/Net Research Expands Global Footprint into South Africa, forming DF/Net Research Mzansi

DF/Net Research Expands Global Footprint into South Africa, forming DF/Net Research Mzansi

JOHANNESBURG, South Africa and SEATTLE, November 2,…

Partner News: Syntrix Pharmaceuticals

Partner News: Syntrix Pharmaceuticals

Syntrix Completes Initial SX-682 Dosing in…

SCDM 2020 Virtual Conference

SCDM 2020 Virtual Conference

  We look forward to exhibiting…